These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 23563670)
41. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. Maupas-Schwalm F; Augé N; Robinet C; Cambus JP; Parsons SJ; Salvayre R; Nègre-Salvayre A FASEB J; 2004 Sep; 18(12):1398-400. PubMed ID: 15231724 [TBL] [Abstract][Full Text] [Related]
42. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae. Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282 [TBL] [Abstract][Full Text] [Related]
43. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites. Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142 [TBL] [Abstract][Full Text] [Related]
44. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet. Baranowski M; Błachnio A; Zabielski P; Górski J J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226 [TBL] [Abstract][Full Text] [Related]
45. [Study of sphingomyelinase activity and sphingomyelin and ceramide levels in comparison with other lipid fractions of the cell nucleus in regenerating rat liver]. Pushkarev MIu; Borovkova OV; Alesenko AV Biokhimiia; 1991 May; 56(5):903-12. PubMed ID: 1747416 [TBL] [Abstract][Full Text] [Related]
46. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease. He X; Chen F; Gatt S; Schuchman EH Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033 [TBL] [Abstract][Full Text] [Related]
47. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis. Allan D Biochem J; 2000 Feb; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519 [TBL] [Abstract][Full Text] [Related]
48. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke. Altura BM; Gebrewold A; Zheng T; Altura BT Brain Res Bull; 2002 Jul; 58(3):271-8. PubMed ID: 12128152 [TBL] [Abstract][Full Text] [Related]
53. Anticancer compounds and sphingolipid metabolism in the colon. Duan RD In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189 [TBL] [Abstract][Full Text] [Related]
54. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents. Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448 [TBL] [Abstract][Full Text] [Related]
55. Distinct effects of ceramide-generating pathways in prostate adenocarcinoma cells. Condorelli F; Canonico PL; Sortino MA Br J Pharmacol; 1999 May; 127(1):75-84. PubMed ID: 10369458 [TBL] [Abstract][Full Text] [Related]
56. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells. Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074 [TBL] [Abstract][Full Text] [Related]
57. [The potential role for sphingolipids in neuropathogenesis of Alzheimer's disease]. Alesenko AV Biomed Khim; 2013; 59(1):25-50. PubMed ID: 23650721 [TBL] [Abstract][Full Text] [Related]